20S proteasome-dependent generation of an IEpp89 murine cytomegalovirus-derived H-2Ld epitope from a recombinant protein

Biochemical and Biophysical Research Communications

Volumn 355, Issue 2, 2007, Pages 549-554

  Voigt, Antje ^a   Salzmann, Ulrike ^a   Seifert, Ulrike ^a   Dathe, Margitta ^b   Soza, Andrea ^a   Kloetzel, Peter Michael ^a   Kuckelkorn, Ulrike ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

Author keywords

pp89; Proteasome; Ubiquitinylation; Viral antigen processing

Indexed keywords

EPITOPE; PROTEASOME; PROTEIN PP89; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL LYSATE; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; BLOTTING, WESTERN; CELL LINE; CIRCULAR DICHROISM; EPITOPES; H-2 ANTIGENS; IMMUNOPRECIPITATION; MICE; MICE, INBRED BALB C; MUROMEGALOVIRUS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; SUBSTRATE SPECIFICITY; UBIQUITIN;

MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1;

EID: 33847182089     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.02.006     Document Type: Article

References (29)

1. Pamer E., and Cresswell P. Mechanisms of MHC class I restricted antigen processing. Annu. Rev. Immunol. 16 (1998) 323-358
2. Kloetzel P.M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell. Biol. 2 (2001) 179-187
3. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., and Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78 (1994) 761-771
4. Ciechanover A., Orian A., and Schwarz A.L. Ubiquitin-mediated proteolysis: biological regulation via destruction. BioEssays 22 (2000) 442-451
5. Asher G., and Shaul Y. p53 proteasomal degradation:poly-ubiquitination is not the whole story. CellCycle 4 (2005) 1015-1018
6. Orlowski M., and Wilk S. Ubiquitin-independent proteolytic functions of the proteasome. Arch. Biochem. Biophys. 415 (2003) 1-5
7. Groll M., Ditzel L., Lowe J., Stock D., Bochtler M., Bartunik H.D., and Huber R. Structure of 20S proteasome from yeast at 2.4 A resolution. Nature 386 (1997) 463-471
8. Boes B., Hengel H., Ruppert T., Multhaup G., Koszinowski U.H., and Kloetzel P.M. Interferon-gamma stimulation modulates the proteolytic activity and the cleavage site preference of 20S mouse proteasomes. J. Exp. Med. 179 (1994) 901-909
9. depitope is generated and translocated into the endoplasmic reticulum as an 11-mer precursor peptide. J. Immunol. 167 (2001) 1515-1521
10. Dick T.P., Ruppert T., Groettrup M., Kloetzel P.M., Kuehn L., Koszinowski U.H., Stevanovic S., Schild H., and Rammensee H.G. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 86 (1996) 253-256
11. Grant E.P., Michalek M.T., Goldberg A.L., and Rock K.L. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J. Immunol. 155 (1995) 3750-3758
12. Princiotta M.F., Finzi D., Qian S.B., Gibbs J., Schuchmann S., Buttgereit F., Bennink J.R., and Yewdell J.W. Quantitating protein synthesis, degradation, and endogenous antigen processing. Immunity 18 (2003) 343-354
13. Schubert U., Anton L.C., Gibbs J., Norbury C.C., Yewdell J.W., and Bennink J.R. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404 (2000) 770-774
14. Asher G., Reuven N., and Shaul Y. 20S proteasomes and protein degradation "by default". Bioessays 28 (2006) 844-849
15. Böhm G., Muhr R., and Jaenicke R. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng. (1992) 191-195
16. Kuckelkorn U., Antunes Ferreira E., Drung I., Liewer U., Kloetzel P.M., and Theobald M. The effect of the interferon-( inducible processing machinery on the generation of a naturally tumor-associated human cytotoxic T lymphocyte epitope within a wild type and mutant p53 sequence context. Eur. J. Immunol. 32 (2002) 1368-1375
17. Ben-Shahar S., Komlosh A., Nadav E., Shaked I., Ziv T., Admon A., DeMartino G.N., and Reiss Y. 26 S proteasome-mediated production of an authentic major histocompatibility class I-restricted epitope from an intact protein substrate. J. Biol. Chem. 274 (1999) 21963-21972
18. Benaroudj N., Tarcsa E., Cascio P., and Goldberg A.L. The unfolding of substrates and ubiquitin-independent protein degradation by proteasomes. Biochimie 83 (2001) 311-318
19. Jariel-Encontre I., Pariat M., Martin F., Carillo S., Salvat C., and Piechaczyk M. cJun was not degraded by the 20S proteasome, whereas it was degraded by the 26S proteasome, but only in the presence of ATP. J. Biol. Chem. 270 (1995) 11623-11627
20. Nunan J., Shearman M.S., Checler F., Cappai R., Evin G., Beyreuther K., Masters C.L., and Small D.H. Regulation of APP cleavage by alpha-, beta- and gamma-secretases. Eur. J. Biochem. 268 (2001) 5329-5336
21. Tarcsa E., Szymanska G., Lecker S., O'Conner C.M., and Goldberg A.L. Ca2+-free calmodulin and calmodulin damaged byin vitroaging are selectively degraded by 26 S proteasomes without ubiquitination. J. Biol. Chem. 275 (2000) 20295-20301
22. Tofaris G.K., Layfield R., and Spillantini M.G. alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 509 (2001) 22-26
23. Kisselev A.F., Kaganovich D., and Goldberg A.L. Binding of hydrophobic peptides to several non-catalytic sites promotes peptide hydrolysis by all active sites of 20S proteasomes. J. Biol. Chem. 277 (2002) 22260-22270
24. Liu C.W., Corboy M.J., DeMartino G.N., and Thomas P.J. Endoproteolytic activity of the proteasome. Science 299 (2003) 408-411
25. Whitby F.G., Masters E.I., Kramer L., Knowlton J.R., Yao Y., Wang C.C., and Hill C.P. Structural basis for the activation of 20S proteasome by 11S regulators. Nature 408 (2000) 115-120
26. Eggers M., Boes-Fabian B., Ruppert T., Kloetzel P.M., and Koszinowski U.H. The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 182 (1995) 1865-1870
27. Zhang M., Thurig S., Tsirigotis M., Wong P.K., Reuhl K.R., and Gray D.A. Effects of mutant ubiquitin on ts1 retrovirus-mediated neuropathology. J. Virol. 77 (2003) 7193-7201
28. Asher G., and Shaul Y. p53 proteasomal degradation: poly-ubiquitination is not the whole story. CellCycle 4 (2005) 1015-1018
29. Sheaff R.J., Singer J.D., Swanger J., Smitherman M., Roberts J.M., and Clurman B.E. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol. Cell. 5 (2000) 403-410